Scientific and technological innovation brings together core driving forces for enterprise development-Media attention-Jiangsu Kanion Pharmaceutical Co.,Ltd.
Original link: http://news.xhby.net/system/2015/03/11/023961931.shtml
National People's Congress deputy
Xiao Wei, Chairman of Jiangsu Kangyuan Group Co., Ltd.:
Jiangnan Times reporter Liu Danping and intern Shi Hongyan
Xiao Wei, deputy to the National People's Congress and chairman of Jiangsu Kangyuan Group Co., Ltd.
When Xiao Wei, deputy to the National People's Congress and chairman of Jiangsu Kangyuan Group Co., Ltd., connected with reporters, he believed that enterprises are the main force of innovation and the backbone of social development. At present, the new situation does bring new challenges. Now, many companies are beginning to feel unprecedented pressure to survive and develop. Facing the new situation, only by actively innovating can enterprises seize the opportunities of personalized and diversified domestic market demand, actively respond to the challenges of increasingly fierce competition in the international market, and achieve industrial transformation and upgrading. During the two sessions, Premier Li Keqiang proposed the "double goals, dual integration, and dual engines" in the government work report, especially emphasizing the two major competitive highlands of emerging industries and emerging business formats. As a national technological innovation demonstration enterprise located in the "One Road, One Belt" construction, the New Eurasian Continental Bridge and the Yangtze River Economic Belt, Kangyuan will also consciously integrate into the national innovation-driven strategy, in line with the "mass entrepreneurship and innovation" proposed by Premier Li Keqiang, and further activate the strategic layout of microeconomic entities to welcome the "golden age" of innovative entrepreneurs.
"In short, development is the hard truth, and innovation is the hard work. Without innovation, there will be no development. Similarly, the development of traditional Chinese medicine is also inseparable from innovation. In recent years, the development of Kangyuan has benefited from the state's support for innovation in the traditional Chinese medicine industry and the consistent innovation development strategy. In the country's policy guidance to encourage innovation Next, in 2015 and during the upcoming 13th Five-Year Plan period, Kangyuan will strengthen the construction of high-level technological innovation platforms, focus on the high-end strategic positioning of collaborative innovation, and realize the transformation and upgrading from innovative traditional Chinese medicines to the research and development of "traditional Chinese medicines, chemical medicines, biopharmaceuticals and health products," said Representative Xiao Wei.
At the same time, with the advent of the "Internet +" era, the company is planning and deploying an Internet marketing model that will strategically integrate the group's existing platform resources such as pharmaceutical retail chains and health foods, with the big health industry as the main body, relying on big data and Internet platforms, and deploy existing manufacturing platform product lines. This will also, together with the innovation-driven strategy, build the "dual engines" for Kangyuan's future development.
Jiangnan Times reporter Liu Danping and intern Shi Hongyan
Original title:
Editor: Xiang Xianjun, Wang Yao